Board of Directors

Philippe Amouyal, Director

Philippe joined Invus in 1999 as a Managing Director, based in Boston. Prior to joining Invus, Philippe spent 15 years at The Boston Consulting Group in Paris and Boston, where he was a Vice President and Director and coordinated the global electronics and software practice from 1991 on. He holds an MS in engineering and a DEA in management from Ecole Centrale de Paris and was a Research Fellow at the Center for Policy Alternatives of the Massachusetts Institute of Technology. Philippe currently serves as a director for Weight Watchers International (NYSE: WTW), Lexicon Pharmaceuticals (NASDAQ:LXRX), and previously was a director at Unwired Group (ASX: UNW).

Jamie Heywood, Co-Founder and Chairman

When his brother Stephen was diagnosed with ALS in 1999, Jamie founded the world's first non-profit biotech, the ALS Therapy Development Institute. As its CEO for 8 years, Jamie grew ALS TDI to be the world's largest ALS research program. He completed the first published stem cell transplant in ALS, developed a unique high throughput in vivo drug validation program, collaborated with dozens of companies, and brought 2 drugs to clinical trial. An engineering graduate of MIT, Jamie’s unique approach to disease research and management has been profiled by Pulitzer Prize winning author Jonathan Weiner in the biography His Brother’s Keeper, 60 Minutes, The New Yorker, and in the Sundance award winning documentary So Much So Fast.

Jun Wang, Director

Dr. Wang co-founded Beijing Genomics Institute (BGI) in 1999, which is now widely recognized as one of world’s premier research facilities committed to excellence in genome sciences. During this time, Dr. Wang managed three rounds of fundraising (about 1B$ in total), and acquired a U.S. public company, Complete Genomics. He was recognized with numerous awards and nominations, such as His Royal Highness Prince Foundation, and “Fortune’s 40 under 40” by Fortune Magazine (2013) and “Highly Cited Researchers 2015” by Thomson Reuters. Dr. Wang founded iCarbonX in 2015. He holds a bachelor’s degree in artificial intelligence and a Ph.D. in bioinformatics from Peking University.

Chun Wu, Director

Dr. Wu joined the Boston Consulting Group (BCG) in 2003. As the global Partner and Managing Director, Dr. Wu led her team to assist multinational and domestic companies to formulate corporate strategy and improve business management. Dr. Wu later joined the Beijing Genomics Institute as the Chief Operating Officer, overseeing manufacturing, marketing and sales globally. Most recently Dr. Wu co-founded and became COO of iCarbonX. Dr. Wu holds a bachelor’s degree in biology from Peking University and a Ph.D. in genetics from Yale University.